The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists.

Dopamine neurotransmitter and its receptors play a critical role in the cell signaling process responsible for information transfer in neurons functioning in the nervous system. Development of improved therapeutics for such disorders as Parkinson's disease and schizophrenia would be significantly enhanced with the availability of the 3D structure for the dopamine receptors and of the binding site for dopamine and other agonists and antagonists. We report here the 3D structure of the long isoform of the human D2 dopamine receptor, predicted from primary sequence using first-principles theoretical and computational techniques (i.e., we did not use bioinformatic or experimental 3D structural information in predicting structures). The predicted 3D structure is validated by comparison of the predicted binding site and the relative binding affinities of dopamine, three known dopamine agonists (antiparkinsonian), and seven known antagonists (antipsychotic) in the D2 receptor to experimentally determined values. These structures correctly predict the critical residues for binding dopamine and several antagonists, identified by mutation studies, and give relative binding affinities that correlate well with experiments. The predicted binding site for dopamine and agonists is located between transmembrane (TM) helices 3, 4, 5, and 6, whereas the best antagonists bind to a site involving TM helices 2, 3, 4, 6, and 7 with minimal contacts to TM helix 5. We identify characteristic differences between the binding sites of agonists and antagonists.

[1]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[2]  Abhinandan Jain,et al.  A fast recursive algorithm for molecular dynamics simulation , 1993 .

[3]  Abhinandan Jain,et al.  Constant temperature constrained molecular dynamics: The Newton-Euler inverse mass operator method , 1996 .

[4]  G M Shepherd,et al.  Molecular mechanisms underlying differential odor responses of a mouse olfactory receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Todd J. A. Ewing,et al.  Critical evaluation of search algorithms for automated molecular docking and database screening , 1997 .

[6]  S. Snyder,et al.  Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. , 1976, Molecular pharmacology.

[7]  P. Strange,et al.  Mechanisms of ligand binding and efficacy at the human D2(short) dopamine receptor , 2002, Journal of neurochemistry.

[8]  Mark Froimowitz,et al.  Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists. , 1994, Journal of medicinal chemistry.

[9]  Sharon Brunett,et al.  Molecular dynamics for very large systems on massively parallel computers: The MPSim program , 1997 .

[10]  W. Goddard,et al.  Mechanism for antibody catalysis of the oxidation of water by singlet dioxygen , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Ballesteros,et al.  A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. , 1998, Biochemistry.

[12]  W. Goddard,et al.  Atomic level simulations on a million particles: The cell multipole method for Coulomb and London nonbond interactions , 1992 .

[13]  J. Leysen,et al.  Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding. , 1978, Biochemical pharmacology.

[14]  Jerry Avorn.  Technology , 1929, Nature.

[15]  Nagarajan Vaidehi,et al.  Virtual screening for binding of phenylalanine analogues to phenylalanyl-tRNA synthetase. , 2002, Journal of the American Chemical Society.

[16]  William A. Goddard,et al.  Fidelity of Phenylalanyl-tRNA Synthetase in Binding the Natural Amino Acids , 2003 .

[17]  P. Seeman,et al.  Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors , 1998, Molecular Psychiatry.

[18]  S. L. Mayo,et al.  DREIDING: A generic force field for molecular simulations , 1990 .

[19]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[20]  W. Goddard,et al.  Structure-based design of mutant Methanococcus jannaschii tyrosyl-tRNA synthetase for incorporation of O-methyl-l-tyrosine , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  W. Goddard,et al.  Charge equilibration for molecular dynamics simulations , 1991 .

[22]  J. Ballesteros,et al.  Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice. , 1996, Biochemistry.

[23]  Roland L. Dunbrack,et al.  Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. , 1997, Journal of molecular biology.

[24]  T. Gudermann,et al.  The structural basis of G-protein-coupled receptor function and dysfunction in human diseases. , 2002, Reviews of physiology, biochemistry and pharmacology.

[25]  A. Dolphin,et al.  The G protein-linked receptor facts book Edited by S. Watson and S. Arkinstall. Academic Press, 427 pp. Price £19.50 , 1994, Neuroscience.

[26]  Pieter F. W. Stouten,et al.  Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..

[27]  J. Ballesteros,et al.  Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. , 1999, Molecular pharmacology.

[28]  Nagarajan Vaidehi,et al.  HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases. , 2004, Journal of medicinal chemistry.

[29]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[30]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[31]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[32]  Wely B. Floriano,et al.  Interaction of e. coli outer‐membrane protein A with sugars on the receptors of the brain microvascular endothelial cells , 2002, Proteins.

[33]  S. Watson,et al.  The G-Protein Linked Receptor Facts Book , 1994 .

[34]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[35]  M. Baudry,et al.  3H-Domperidone: A selective ligand for dopamine receptors , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.

[36]  D. M. Jackson,et al.  Dopamine receptors: molecular biology, biochemistry and behavioural aspects. , 1994, Pharmacology & therapeutics.

[37]  Peter L. Freddolino,et al.  Prediction of structure and function of G protein-coupled receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Ballesteros,et al.  The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.

[39]  H. Wikström,et al.  Further characterization of structural requirements for ligands at the dopamine D(2) and D(3) receptor: exploring the thiophene moiety. , 2002, Journal of medicinal chemistry.

[40]  P. Strange.  Dopamine Receptors: Studies on Structure and Function , 1996 .

[41]  Lei Shi,et al.  The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. , 2002, Annual review of pharmacology and toxicology.